ストックスクリーナーアプリを入手
27.95
7.20%
1.5662
前日終値:
$26.38
開ける：
$25.73
24時間の取引高:
288.82K
Relative Volume:
1.40
時価総額：
$352.13M
収益：
-
当期純損益:
$-51.74M
株価収益率:
-6.2884
EPS:
-4.4441
ネットキャッシュフロー:
$-44.57M
1週間 パフォーマンス:
+14.91%
1か月 パフォーマンス:
-3.35%
6か月 パフォーマンス:
+104.34%
1年 パフォーマンス:
+244.88%
1日の値動き範囲:
$25.73
$29.62
1週間の範囲:
$22.01
$29.62
52週間の値動き範囲:
$4.90
$35.62
Forte Biosciences Inc Stock (FBRX) Company Profile
名前
Forte Biosciences Inc
セクター
電話
(310) 618-6994
住所
3060 PEGASUS PARK DRIVE, DALLAS, CA
Compare FBRX vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FBRX
Forte Biosciences Inc
|
28.11 | 330.46M | 0 | -51.74M | -44.57M | -4.4441 |
VRTX
Vertex Pharmaceuticals Inc
|
456.48 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
758.51 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
332.00 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
694.61 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
149.35 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-25 | 開始されました | Evercore ISI | Outperform |
| 2025-08-18 | 開始されました | Guggenheim | Buy |
| 2025-01-21 | 開始されました | TD Cowen | Buy |
| 2024-04-08 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2021-09-20 | アップグレード | Chardan Capital Markets | Sell → Buy |
| 2021-09-03 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2021-09-03 | ダウングレード | Chardan Capital Markets | Buy → Sell |
| 2021-09-03 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2021-09-03 | ダウングレード | Truist | Buy → Hold |
| 2021-05-14 | 開始されました | B. Riley Securities | Buy |
| 2021-03-26 | 開始されました | Citigroup | Buy |
| 2020-08-28 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2020-08-25 | 開始されました | Truist | Buy |
すべてを表示
Forte Biosciences Inc (FBRX) 最新ニュース
Technical Reactions to FBRX Trends in Macro Strategies - Stock Traders Daily
Rally Mode: Is Forte Biosciences Inc a top pick in the sectorEarnings Miss & Growth Oriented Trade Recommendations - baoquankhu1.vn
Forte Biosciences Inc expected to post a loss of $1.21 a shareEarnings Preview - TradingView
Pullback Watch: Will Forte Biosciences Inc announce a stock splitQuarterly Performance Summary & High Win Rate Trade Tips - baoquankhu1.vn
If You Invested $1,000 in Forte Biosciences Inc (FBRX) - Stock Titan
FBRX Stock Price, Quote & Chart | FORTE BIOSCIENCES INC (NASDAQ:FBRX) - ChartMill
Forte Biosciences (FBRX) Projected to Post Earnings on Friday - MarketBeat
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - MarketBeat
Aug Fed Impact: Does Forte Biosciences Inc have pricing power2026 Price Targets & Growth Focused Investment Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - The Joplin Globe
Mink Brook Asset Management LLC Buys 42,419 Shares of Forte Biosciences, Inc. $FBRX - MarketBeat
New hires at Forte Biosciences get options on 25,000 shares - Stock Titan
Trading the Move, Not the Narrative: (FBRX) Edition - Stock Traders Daily
History Review: Can Forte Biosciences Inc maintain its current growth rateGap Up & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
FBRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
FBRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Bank Watch: Can LOKV lead its sector in growth2025 Support & Resistance & Momentum Based Trading Ideas - baoquankhu1.vn
Can Forte Biosciences Inc. stock beat analyst upgradesEarnings Beat & Growth Focused Stock Pick Reports - Naître et grandir
Can Forte Biosciences Inc. stock maintain growth trajectoryWeekly Loss Report & Technical Confirmation Alerts - Naître et grandir
Portfolio Update: Can MKTW withstand a market correction2025 Analyst Calls & Community Verified Trade Alerts - baoquankhu1.vn
Forte Biosciences (FBRX) Price Target Increased by 16.98% to 53.30 - MSN
Forte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX) - Defense World
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules - marketscreener.com
Vitiligo Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com
Stock Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat
Biotech Forte Biosciences hands 100,000 stock options to new hires - Stock Titan
Celiac Disease Market: Expanding Revenue Landscape to 2034 – DelveInsight | Zedira, Dr. Falk Pharma, Takeda, ImmunoGenX, Provention Bio, Sanofi, Topas Therapeutics GmbH, Pfizer - StreetInsider
(FBRX) Volatility Zones as Tactical Triggers - Stock Traders Daily
FBRX PE Ratio & Valuation, Is FBRX Overvalued - Intellectia AI
Forte Biosciences (FBRX) Raised to Buy: Key Information You Need - Bitget
Forte Biosciences (FBRX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Pullback Watch: Is Forte Biosciences Inc a top pick in the sector2025 Risk Factors & Low Volatility Stock Suggestions - baoquankhu1.vn
Is Forte Biosciences Inc. a top pick in the sectorWeekly Stock Summary & Weekly Watchlist for Hot Stocks - mfd.ru
Will Forte Biosciences Inc. benefit from rate cutsQuarterly Portfolio Report & Stepwise Swing Trade Plans - mfd.ru
Price-Driven Insight from (FBRX) for Rule-Based Strategy - Stock Traders Daily
Stock Traders Purchase Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat
Analyst Downgrade: Is Forte Biosciences Inc stock a good dividend stockCEO Change & Growth Focused Entry Reports - baoquankhu1.vn
We Think Forte Biosciences (NASDAQ:FBRX) Can Afford To Drive Business Growth - Yahoo Finance
Celiac Disease Clinical Trial Pipeline Gains Momentum as 25+ - openPR.com
Growth Recap: How much upside does KWESST Micro Systems Inc Equity Warrant havePortfolio Performance Summary & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Why Forte Biosciences Inc. stock is popular among millennialsJuly 2025 Reactions & Daily Profit Maximizing Tips - mfd.ru
Forte Biosciences, Inc. (NASDAQ:FBRX) Sees Large Decrease in Short Interest - MarketBeat
Why Airbnb Inc. stock is favored by top institutionsJuly 2025 Institutional & Reliable Price Breakout Alerts - mfd.ru
Celiac Disease Clinical Trial Pipeline Gains Momentum As 25+ Companies Advance Novel Therapies Toward Market Entry: Delveinsight Teva Pharmaceutical Industries, Barinthus Biotherapeutics, Topas - Menafn.com
Will Forte Biosciences Inc. stock deliver better than expected guidanceQuarterly Earnings Report & Proven Capital Preservation Tips - mfd.ru
Is Forte Biosciences Inc. stock a good choice for value investors2025 Technical Patterns & AI Forecast for Swing Trade Picks - mfd.ru
Can Forte Biosciences Inc. maintain its current growth rateDollar Strength & AI Powered Buy/Sell Recommendations - mfd.ru
Institutional Owners May Ignore Forte Biosciences, Inc.'s (NASDAQ:FBRX) Recent US$87m Market Cap Decline as Longer-term Profits Stay in the Green - 富途牛牛
Does Forte Biosciences Inc. have pricing powerPortfolio Performance Summary & Growth Focused Stock Pick Reports - mfd.ru
Forte Biosciences Inc (FBRX) 財務データ
収益
当期純利益
現金流量
EPS
Forte Biosciences Inc (FBRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Jan 01 '26 |
Option Exercise |
0.00 |
375 |
0 |
41,895 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Dec 30 '25 |
Buy |
26.33 |
9,680 |
254,833 |
41,520 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Oct 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,974 |
| Wagner Paul A. | SEE REMARKS |
Oct 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
82,190 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Jul 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,733 |
| Wagner Paul A. | SEE REMARKS |
Jul 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
81,038 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Apr 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,372 |
| Wagner Paul A. | SEE REMARKS |
Apr 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
79,806 |
0.99%
3.03%
大文字化:
|
ボリューム (24 時間):